Revolution Medicines Inc

Predicción y previsión de precio de Revolution Medicines Inc (RVMD)

$186.990

-0.692 (-0.37%)Al cierre

Predicciones de precio

1-Day Price Prediction
+1.83%
1-Week Prediction
+1.69%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

Ábrelo en la app para desbloquear previsiones a más largo plazo.

Loading chart…

Predicción y previsión de RVMD por análisis de gráficos similares

Alphio's RVMD stock price prediction model matches the current Revolution Medicines Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $187.22 (+1.83%). The 1-week path is $186.97 (+1.69%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

¿Debería comprar acciones de Revolution Medicines Inc?

Revolution Medicines Inc is a good buy right now due to its recent approval of the drug Rasonque, which has a projected sales potential of $15.1 billion by 2034. The current price is $186.99, with an analyst price target of $259.14 suggesting a 38.3% upside. However, the company is facing significant losses, with a projected EPS of -2.35 for the next earnings report, which is a key risk to consider.

RVMD cerró en $186.99 el Friday, tras bajar -0.37%

Revolution Medicines Inc (RVMD) last closed at $183.8600006, losing -1.67%. These facts feed the 1-day and 1-week RVMD price prediction above.

Factores de la previsión

Los factores de la previsión de Revolution Medicines Inc (RVMD) combinan patrones gráficos similares, estacionalidad y medias móviles.

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Negative

Bearish

SMA 200

Positive

Bullish

Patrones gráficos similares

Acciones cuya trayectoria reciente más se parece a la de RVMD, ordenadas por similitud.

Análisis de estacionalidad de RVMD

Historically the probability of a positive October return for RVMD is 100.00%. October offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar